HIGH
CVE-2022-47376
CWE-257Published: June 13, 2023· Updated: Jun 17, 2026
7.3
CVSS v3.1
Official Description
The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data.
Technical Analysis
CVE-2022-47376 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 7.3.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorLocal
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityLow
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Affected Vendors & Products
bd1 product(s)
alaris infusion central
Source: NVD CPE · 1 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (2)
Quick Facts
CVE IDCVE-2022-47376
CVSS Score7.3 / 10
SeverityHIGH
WeaknessCWE-257
CISA KEVNo
Affected1 vendor(s)
PublishedJun 13, 2023
Related CVEs (CWE-257)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2022-47376 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.